DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Nabilone in Cannabis Users With PTSD

Phase 1

Terminated

Conditions: Cannabis
Post Traumatic Stress Disorder

Interventions: Drug: Placebo
Drug: Nabilone
Drug: Propranolol
Drug: Cannabis

First Posted Date: 2017-08-16

Last Posted Date: 2022-07-15

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 4

Registration Number: NCT03251326

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

Phase 1

Terminated

Conditions: Glioblastoma

Interventions: Drug: Cannabis
Drug: Temozolomide
Radiation: Radiation Therapy

First Posted Date: 2017-08-11

Last Posted Date: 2019-08-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 1

Registration Number: NCT03246113

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
🇺🇸
Columbia University Medical Center- Department of Radiation Oncology, New York, New York, United States

A Novel Computer-Based Therapy for Social Anxiety

Not Applicable

Suspended

Conditions: Social Anxiety Disorder

Interventions: Behavioral: GC-MRT
Behavioral: modified GC-MRT
Behavioral: Non-GC-MRT

First Posted Date: 2017-08-04

Last Posted Date: 2025-02-03

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 60

Registration Number: NCT03240003

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders

Phase 3

Completed

Conditions: Opioid-use Disorder

Interventions: Drug: Vivitrol
Drug: Buprenorphine

First Posted Date: 2017-07-28

Last Posted Date: 2022-11-07

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 11

Registration Number: NCT03232346

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Safety Planning Intervention to Reduce Short Term Risk

Not Applicable

Completed

Conditions: Suicide, Attempted

Interventions: Behavioral: Risk factors and Warning signs
Behavioral: Safety Planning Intervention

First Posted Date: 2017-07-24

Last Posted Date: 2024-01-05

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 422

Registration Number: NCT03227991

Locations: 🇺🇸
University of Massachusetts, Worcester, Massachusetts, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Pharmacogenetics of Naltrexone for Stimulant Abuse

Phase 2

Completed

Conditions: Substance Use Disorders
Methamphetamine Abuse

Interventions: Drug: Intranasal Methamphetamine

First Posted Date: 2017-07-21

Last Posted Date: 2020-11-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 18

Registration Number: NCT03226223

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment

Not Applicable

Terminated

Conditions: Smoking Cessation
Tobacco Use
Tobacco Smoking
Nicotine Use Disorder
Cigarette Smoking
Nicotine Dependence
Smoking
Tobacco Dependence
Tobacco Use Disorder
Smoking, Cigarette

Interventions: Behavioral: Contingency management

First Posted Date: 2017-07-11

Last Posted Date: 2023-01-05

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 11

Registration Number: NCT03213418

Locations: 🇺🇸
NYSPI, STARS Clinic, 3 Columbus Circle, suite 1408, 14th Floor, New York, New York, United States

The Anti-Inflammatory Effects of Exercise and Peanut Consumption

Not Applicable

Terminated

Conditions: Peanut Consumption
High Intensity Aerobic Exercise

Interventions: Other: Peanut Consumption
Other: High Intensity Interval Training

First Posted Date: 2017-07-11

Last Posted Date: 2020-04-06

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 3

Registration Number: NCT03212144

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Medication Development for Opioid and Alcohol Abuse

Phase 2

Completed

Conditions: Alcohol Use Disorder
Opioid-use Disorder

Interventions: Drug: Gabapentin

First Posted Date: 2017-07-02

Last Posted Date: 2022-10-06

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 17

Registration Number: NCT03205423

Locations: 🇺🇸
New York State Psychiatric Institute in the Division on Substance Use Disorders, New York, New York, United States

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment

Not Applicable

Active, not recruiting

Conditions: Cognitive Disorder
Mild Cognitive Impairment
Memory Impairment
Memory Disorders
Cognitive Impairment
Cognitive Decline

Interventions: Other: Computerized Cognitive Training
Other: Crossword Puzzles

First Posted Date: 2017-07-02

Last Posted Date: 2022-10-04

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 107

Registration Number: NCT03205709

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy